Empowering Oncology Decisions

DiagnoCure is a life sciences company commercializing high-value cancer diagnostic tests and lab services that increase clinician and patient confidence in making critical treatment decisions.

Special Announcement

Beginning of a U.S. clinical study intended to secure U.S. FDA regulatory approval of the PROGENSA PCA3 assay

Visit our media room for more information